← FDA Drug Approvals (Drugs@FDA)

ABLYSINOL

NDA · New Drug Application · Sponsor: BPI LABS · Approved 2018-06-21

Drug application

FDA Application #

NDA207987

Application type

New Drug Application

Brand name

ABLYSINOL

Generic name

ALCOHOL

Active ingredients

DEHYDRATED ALCOHOL

Dosage form

SOLUTION

Route

INTRA-ARTERIAL

Marketing status

Prescription

Sponsor

BPI LABS

Manufacturer

Ajenat Pharmaceuticals LLC

First approval

2018-06-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown